Hormone Replacement Therapy: What's Science and What's Speculation? What More do we Need to Know?

References

• The writing group for the PEPI trial: Effects of estrogen or estrogen/progestin regimen on heart disease risk factors in postmenopausal women. The postmenopausal estrogen/progestin intervention (PEPI) trial. JAMA 1995; 273: 199–208.
   PubMed Web of Science ®Google Scholar
• Sarrel PM, Lufkin ES, Oursler MJ, Keefe D: Estrogen actions in arteries, bone, and brain. Scientific American Science and Medicine 1994;July/August: 44–53.
   Google Scholar
• McGill HC Jr: Sex steroid hormone receptors in the cardiovascular system. Postgrad Med 1989; 85: 64–68.
   Google Scholar
• Landers JP, Spelsberg TC: New concepts in steroid hormone action: transcription factors, proto-oncogenes, and the cascade model for steroid regulation of gene suppression. Crit Rev Eukaryot Gene Expr 1992; 2 (1): 19–63.
   Google Scholar
• Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Kore M, Greene GL, O'Malley BW, Haussler MR: Estrogen binding, receptor mRNA and biologic response in osteoblast-like osteosarcoma cells. Science 1988; 241: 81–84.
   PubMed Web of Science ®Google Scholar
• Bitran D, Lan NC, Gee KW: Anxiolytic effects of 3 alpha hydroxy-5-alpha [betal-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res 1991; 561: 157–161.
   PubMed Web of Science ®Google Scholar
• Majewska MD, Harrison NL, Schwartz RD, Baker JL, Paul SM: Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986; 232: 1004–1007.
   PubMed Web of Science ®Google Scholar
• Backstrom T, Bixo M, Hammarback S: Ovarian steroid hormones: effects on mood, behavior and brain excitability. Acta Obstet Gynecol Scand Suppl 1985; 130: 19–24.
   PubMedGoogle Scholar
• Gee KW: Steroid modulation of the GABA/benzodiazepine receptor-linked chloride ionophore. Mol Neurobiol 1988; 2: 291–317.
   PubMed Web of Science ®Google Scholar
• McEwen BS, Woolley CS: Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol 1994; 29: 431–436.
   PubMed Web of Science ®Google Scholar
• Woolley CS, McEwen MS: Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 1992; 12: 2549–2554.
   PubMed Web of Science ®Google Scholar
• Robinson D, Friedman L, Marcus R, Tinklenberg J, Yesavage J: Estrogen replacement therapy and memory in older women. J Am Geriatr Soc 1994; 42: 919–922.
   PubMed Web of Science ®Google Scholar
• Ditkoff EC, Crary WG, Cristo M, Lobo RA: Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991; 78: 991–995.
   PubMed Web of Science ®Google Scholar
• Palinkas LA, Barrett-Connor E: Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol 1992; 80: 30–36.
   PubMed Web of Science ®Google Scholar
• Seeley DG, Cauley JA, Grady D, Browner WS, Nevitt MC, Cummings SR: Is postmenopausal estrogen therapy associated with neuromuscular function or falling in elderly women? A study of Osteoporotic Fractures Research Group. Arch Intern Med 1995; 155: 293–299.
   PubMed Web of Science ®Google Scholar
• Sarrel PM: Ovarian hormones and the circulation. Maturitas 1990; 12: 287–298.
   PubMed Web of Science ®Google Scholar
• Collins P, Rosano GM, Jiany C, Lindsay D, Sarrel PM, Poole-Wilson PA: Cardiovascular protection by oestrogen—a calcium antagonist effect? Lancet 1993; 341: 1264–1265.
   PubMed Web of Science ®Google Scholar
• Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373–376.
   PubMed Web of Science ®Google Scholar
• Mugge A, Riedel M, Barton M, Kuhn M, Lichtlen PR: Endothelium independent relaxation of human coronary arteries by 17 beta-oestradiol in vitro. Cardiovasc Res 1993; 27: 1939–1942.
   PubMed Web of Science ®Google Scholar
• Rosano GM, Sarrel PM, Poole-Wilson PA, Collins P: Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 1993; 342: 133–136.
   PubMed Web of Science ®Google Scholar
• Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM: Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325: 1196–1204.
   PubMed Web of Science ®Google Scholar
• Ettinger B: Hormone replacement therapy and coronary artery disease. Obstet Gynecol Clin North Am 1990; 17: 741–757.
   Web of Science ®Google Scholar
• Jensen J, Riis BJ, Strom V, Nilas L, Christiansen C: Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women. Am J Obstet Gynecol 1987; 156: 66–71.
   PubMed Web of Science ®Google Scholar
• Jensen J, Nilas J, Christiansen C: Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy. Br J Obstet Gynaecol 1986; 93: 613–618.
   PubMedGoogle Scholar
• Kronenberg F, Cote L, Linkie DM, Dyrenfurth I, Downey JA: Menopausal hot flashes: thermoregulatory, cardiovascular, and circulating catecholamine and LH changes. Maturitas 1984; 6: 31–43.
   PubMed Web of Science ®Google Scholar
• Kuhn FE, Rackley CE: Coronary artery disease in women: risk factors, evaluation, treatment, and prevention. Arch Intern Med 1993; 153: 2626–2636.
   Google Scholar
• Colditz GA, Willet WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH: Menopause and the risk of coronary heart disease in women. N Engl J Med 1987; 316: 1105–1110.
   PubMed Web of Science ®Google Scholar
• Siddle N, Sarrel PM, Whitehead M: The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review. Fertil Steril 1987; 47: 94–100.
   PubMed Web of Science ®Google Scholar
• Wilson PW, Garrison RJ, Castelli WP: Postmenopausal estrogen use, cigarette smoking and cardiovascular morbidity in women over 50: The Framingham Study. N Engl J Med 1985; 313: 1038–1043.
   PubMed Web of Science ®Google Scholar
• Stampfer MJ, Willet WC, Colditz GA, Rosner B, Speizer FE, Hennekens CH: A prospective study of postmenopausal estrogen therapy and coronary heart disease. N Engl; Med 1985; 313: 1044–1049.
   PubMed Web of Science ®Google Scholar
• Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE: The use of estrogen and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995; 332: 1589–1593.
   PubMed Web of Science ®Google Scholar
• Stampfer MJ, Colditz GA, Willett WC: Menopause and heart disease: a review. Ann N Y Acad Sci 1990; 592: 193–203.
   PubMed Web of Science ®Google Scholar
• Oursler MJ, Landers JP, Riggs BL, Spelsperg TC: Oestrogen effects on osteoblasts and osteoclasts. Ann Med 1993; 25: 361–371.
   PubMed Web of Science ®Google Scholar
• Oursler MJ, Pederson L, Pyfferoen J, Osdoby P, Fitzpatrick L, Spelsberg TC: Estrogen modulation of avian osteoclast lysosomal gene expression. Endocrinology 1993; 132: 1373–1380.
   PubMed Web of Science ®Google Scholar
• Ransone LJ, Verma IM: Nuclear proto-oncogenes fos and jun. Annu Rev Cell Biol 1990; 6: 539–557.
   PubMedGoogle Scholar
• Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016–1037.
   PubMed Web of Science ®Google Scholar
• Healy B: PEPI in perspective: good answers spawn pressing questions [editorial]. JAMA 1995; 273: 240–241.
   Web of Science ®Google Scholar
• Sullivan JM: Hormone replacement in the secondary prevention of cardiovascular disease. In Wenger NK, Sperfoff L, Packard B, eds: Cardiovascular Health and Disease in Women. Greenwich, Conn.: LeJacq Communications, Inc., 1993: 189–194.
   Google Scholar
• Paganini-Hill A: The risks and benefits of estrogen replacement therapy: Leisure World. Int J Fertil Menopausal Stud 1995; 40 Suppl 1: 54–62.
   Google Scholar
• Committee to Review the NIH Women's Health Initiative, Food and Nutrition Board, and Board of Health Sciences Policy of the Institute of Medicine: An Assessment of the NIH Women's Health Initiative. Washington, D.C.: National Academy Press, 1993.
   Google Scholar
• Belchetz PE: Hormonal treatment of postmenopausal women. N Engl J Med 1994; 330: 1062–1071.
   PubMed Web of Science ®Google Scholar
• MacDonald PC, Dombroski RA, Casey ML: Recurrent secretion of progesterone in large amounts: an endocrine/metabolic disorder unique to young women? Endocr Rev 1991; 12: 372–401.
   PubMed Web of Science ®Google Scholar
• The Coronary Drug Project Research Group: The coronary drug project: findings leading to discontinuation of the 2.5 mg day estrogen group. JAMA 1973; 226: 652–657.
   PubMedGoogle Scholar
• Cohen JHM, Danel L, Gordier G, Saez S, Revillard JP: Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT 8 positive cells. J Immunol 1983; 131: 2767–2771.
   PubMed Web of Science ®Google Scholar
• Danel L, Sovweine G, Monier JC, Szea S: Specific estrogen binding sites in human lymphoid cells and thymic cells. J Steroid Biochem Mol Biol 1983; 18: 559–563.
   Web of Science ®Google Scholar
• Paaveone T, Andersson LC, Adlercreutz H: Sex hormone regulation of in vitro immune response: estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen stimulated cultures. J Exp Med 1981; 154: 1935–1945.
   Web of Science ®Google Scholar